Delivery Order SPE2DB24D8002-SPE2DB25FJPLU
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $5,140.21 firm fixed price delivery order to Dakota Drug, Inc. of Minot, North Dakota for 200 mg/ml autoinjector vials of Benlysta. The order, placed under an unspecified governmentwide acquisition contract vehicle, calls for Dakota Drug to deliver the specified pharmaceutical to an address in Minot. No subcontractors or set-aside designations were indicated. The Defense Logistics Agency manages the Department of Defense's global...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,649.64 contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a period of performance ending on March 21, 2024. This award was not set aside. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the...
- Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $3,349.90 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Issued against an existing blanket purchase agreement with no set-aside designation, this delivery order provides BENLYSTA 200 MG/ML autoinjectors with a completion date of December 5, 2023. As the prime contractor, Dakota Drug...
- This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNGD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,575.20, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. This award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical...
- Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $4,599.41 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Issued against an existing blanket purchase agreement with no set-aside designation, this delivery order provides BENLYSTA 200 MG/ML autoinjectors to support DLA Troop Support Medical supply chain operations and maintain stock...
- The Defense Logistics Agency Troop Support Medical awarded a $8,393.59 firm fixed price delivery order to Dakota Drug, Inc. for 4562071268 ! BENLYSTA 200 MG/ML AUTOINJECTML. The place of performance is Minot, North Dakota. The period of performance is September 6-7, 2023. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. Under this order, Dakota Drug will deliver BENLYSTA 200 MG/ML prefilled autoinjectors to support DLA's...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Benlysta 200 mg/mL auto-injector medications. This contract, which is a child award under an existing vehicle, carries an ultimate completion date of September 8, 2025, and involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on August 20, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and other autoimmune...
- The Defense Logistics Agency awarded a $25,912.62 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, non-set-aside contract with a completion deadline of September 12, 2025, with performance executed from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transactional purchase under AmerisourceBergen's larger contract vehicle with DLA. This award...
- The Defense Logistics Agency (DLA) awarded a $15,413.35 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on July 31, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJPLUDelivery Order
The Defense Logistics Agency awarded a $10,101.69 firm fixed price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, carries no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which is valued at $999,999,999.00 and extends through December 31, 2025. Dakota Drug, Inc. serves as a critical pharmaceutical and medical equipment supplier to the Defense Logistics Agency, supporting U.S. Armed Forces medical operations through the provision of diverse medications and healthcare supplies. The company's performance under the parent IDC demonstrates its capability to deliver essential pharmaceutical products, including biologics such as Benlysta, which is used in the treatment of systemic lupus erythematosus and other autoimmune conditions. The delivery will be performed at the company's location in Anoka, Minnesota, continuing Dakota Drug, Inc.'s established role as a key vendor within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 9/4/25 |